Latest Articles

Publication Date
Sharp rise in endometriosis cases alarms Pretoria clinic - The Citizen

Sharp rise in endometriosis cases alarms Pretoria clinic The Citizen

Published: Dec. 5, 2025, 11:04 a.m.
Personalized Estimation of Fatigue in Endometriosis Using Wrist-Worn Actigraphy Data and Hierarchical Bayesian Modeling.

Endometriosis is a common chronic condition associated with debilitating pain and fatigue. Wearable technology has the potential to improve symptom monitoring in endometriosis where symptom severity has been traditionally evaluated …

Published: Dec. 5, 2025, midnight
Bridging bench to bedside: Exosome‑based strategies for endometriosis diagnosis and treatment (Review).

Endometriosis is a complex, chronic inflammatory gynecological disorder with estrogen‑dependent characteristics that severely impairs the quality of life of women and potentially leads to infertility. However, its pathogenesis remains poorly …

Published: Dec. 5, 2025, midnight
Microbiota insights in endometriosis.

Endometriosis affects approximately 10% of women of reproductive age and is characterized by the presence of endometrial-like tissue outside the uterine cavity, leading to chronic pelvic pain, infertility, and a …

Published: Dec. 5, 2025, midnight
Genetic and Epigenetic Components in the Pathogenesis of Adenomyosis and Endometriosis in Adolescents.

Background: Adenomyosis and endometriosis are complex, estrogen-dependent gynecological conditions increasingly diagnosed in adolescents. While traditionally considered diseases of reproductive-age women, emerging evidence suggests a possible developmental origin in some cases, …

Published: Dec. 5, 2025, midnight
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial - TradingView

Absci Announces First Participants Dosed In Phase 1/2A Headline Trial TradingView

Published: Dec. 4, 2025, 1:24 p.m.
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - The Manila Times

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia The Manila Times

Published: Dec. 4, 2025, 1:22 p.m.
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire

Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire

Published: Dec. 4, 2025, 1 p.m.
Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study - Citeline News & Insights

Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study Citeline News & Insights

Published: Dec. 4, 2025, 11:19 a.m.
Marquis Who's Who Honors Elham Neisani Samani, MD, for Excellence in Health Care - 24-7 Press Release

Marquis Who's Who Honors Elham Neisani Samani, MD, for Excellence in Health Care 24-7 Press Release

Published: Dec. 4, 2025, 8:36 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!